ESH CML Highlights: Michele Baccarani Symposium - understanding the significance of mutations in CML
The role of FLOT2 in CML progression & how it differs from AML
Managing cardiovascular risks associated with lifelong TKI therapy in CML
TKI-related toxicities in CML & the importance of long-term monitoring
How COVID-19 has impacted patients with hematological malignancies
Exciting advances in DLBCL: molecular characterization of subtypes & novel immunotherapeutic agents
EHA 2023 CLL highlights
Prognostic markers for the treatment of CLL
ETNK1 mutations precede mitochondrial dysfunction in atypical CML
The efficacy of COVID-19 vaccines in patients with CLL
Impact of novel therapies on post-transplant infection risk
Smart Wearables & Heartbeats Part 2: Athletes
ESC 2020: Downstream or upstream P2Y12 receptor blockers in NSTE-ACS — Dr Giuseppe Tarantini
Iron deficiency: Practical Tips for Common & Longstanding Problem Prof. Ilham Youssry 9th ASPCN
La nuova normativa europea che regola gli studi clinici in Europa accelererà lo sviluppo di farmaci
Tầm soát rung nhĩ và xử trí rung nhĩ dưới lâm sàng
Круглий стіл з обговоренням в секції Аритмологія - XXIII НАЦІОНАЛЬНИЙ КОНГРЕС КАРДІОЛОГІВ УКРАЇНИ
Rhythmologie Update 2021 / Tachykardiomyopathie (#SyGAAD_Webinars 2021) (3)
Qui appareiller par un pacemaker ?. MAC- N.LELLOUCHE
Leucemie, come gestire le complicanze infettive delle terapie target?
